Publications by authors named "Samir Khleif"

Claim this Profile
C
Cancer vaccines as enablers of immunotherapy.
Samir N Khleif, Seema Gupta

Nat Immunol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing public-private partnerships to support clinical cancer research.
Roy S Herbst, Gideon Blumenthal, Samir N Khleif, Scott M Lippman, Neal J Meropol

J Natl Cancer Inst· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation.
Zachary S Morris, Sandra Demaria, Arta M Monjazeb, Silvia C Formenti, Ralph R Weichselbaum, Samir Khleif

Lancet Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The "Great Debate" at Immunotherapy Bridge 2022, Naples, November 30th-December 1st, 2022.
Paolo A Ascierto, Renier Brentjens, Samir N Khleif, Kunle Odunsi, Katayoun Rezvani

J Transl Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PI3K Isoforms in CD8 T Cell Development and Function.
Pankaj Gaur, Mikayel Mkrtichyan, Vivek Verma, Nazli Jafarzadeh, Mariana Hattar, Samir N Khleif

Curr Top Microbiol Immunol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st-2nd, 2021.
Paolo A Ascierto, Antonio Avallone, Nina Bhardwaj, Carlo Bifulco, Sergio Bracarda, Samir N Khleif

J Transl Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IDO Vaccine Ablates Immune-Suppressive Myeloid Populations and Enhances Antitumor Effects Independent of Tumor Cell IDO Status.
Rahul Nandre, Vivek Verma, Pankaj Gaur, Veerupaxagouda Patil, Xingdong Yang, Samir N Khleif

Cancer Immunol Res· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Evidence Generation During a Pandemic: Lessons Learned for Sustaining Progress.
Donna R Rivera, Paul G Kluetz, Kald Abdallah, Sundeep Agrawal, Derek C Angus, Samir N Khleif

Cancer J· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report.
Altaf Mohammed, Roderick H Dashwood, Sally Dickinson, Mary L Disis, Elizabeth M Jaffee, Samir N Khleif

J Cancer Prev· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd-3rd, 2020, Italy).
Paolo A Ascierto, Carlo Bifulco, Fortunato Ciardiello, Sandra Demaria, Leisha A Emens, Samir N Khleif

J Transl Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The State of Melanoma: Emergent Challenges and Opportunities.
Michael B Atkins, Clara Curiel-Lewandrowski, David E Fisher, Susan M Swetter, Hensin Tsao, Samir N Khleif

Clin Cancer Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?
Sandra Demaria, Chandan Guha, Jonathan Schoenfeld, Zachary Morris, Arta Monjazeb, Samir Khleif

J Immunother Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early 3+3 Trial Dose-Escalation Phase I Clinical Trial Design and Suitability for Immune Checkpoint Inhibitors.
Osama E Rahma, Joshua E Reuss, Anita Giobbie-Hurder, Ghazaleh Shoja E Razavi, Osama Abu-Shawer, Samir N Khleif

Clin Cancer Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MEK inhibition reprograms CD8 T lymphocytes into memory stem cells with potent antitumor effects.
Vivek Verma, Nazli Jafarzadeh, Shannon Boi, Subhadip Kundu, Zhinuo Jiang, Samir N Khleif

Nat Immunol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge" (December 4th-5th, 2019, Naples, Italy).
Paolo A Ascierto, Lisa H Butterfield, Katie Campbell, Bruno Daniele, Michael Dougan, Samir N Khleif

J Transl Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shifting the Immune-Suppressive to Predominant Immune-Stimulatory Radiation Effects by SBRT-PArtial Tumor Irradiation Targeting HYpoxic Segment (SBRT-PATHY).
Slavisa Tubin, Seema Gupta, Michael Grusch, Helmuth H Popper, Luka Brcic, Samir N Khleif

Cancers (Basel)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Application of Computational Methods in Precision Oncology: A Review.
Orestis A Panagiotou, Lori Hoffman Högg, Hedvig Hricak, Samir N Khleif, Mia A Levy

JAMA Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Great Debate at 'Immunotherapy Bridge', Naples, December 5, 2019.
Paolo A Ascierto, Carlo Bifulco, Jerome Galon, Claus Garbe, Samir N Khleif

J Immunother Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study.
Dmitriy Zamarin, Robert A Burger, Michael W Sill, Daniel J Powell, Heather A Lankes, Samir Khleif

J Clin Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002).
Alessandro D Santin, Wei Deng, Michael Frumovitz, Natalia Buza, Stefania Bellone, Samir Khleif

Gynecol Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008).
Alessandro D Santin, Virginia Filiaci, Stefania Bellone, Elena S Ratner, Cara A Mathews, Samir N Khleif

Gynecol Oncol Rep· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1CD38 cells and anti-PD-1 resistance.
Vivek Verma, Rajeev K Shrimali, Shamim Ahmad, Winjie Dai, Hua Wang, Samir N Khleif

Nat Immunol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Activity, Tolerability, and Long-Term Follow-Up of Durvalumab in Patients With Advanced NSCLC.
Scott J Antonia, Ani Balmanoukian, Julie Brahmer, Sai-Hong I Ou, Matthew D Hellmann, Samir N Khleif

J Thorac Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1CD38 cells and anti-PD-1 resistance.
Vivek Verma, Rajeev K Shrimali, Shamim Ahmad, Winjie Dai, Hua Wang, Samir N Khleif

Nat Immunol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort.
Neil H Segal, Sai-Hong I Ou, Ani Balmanoukian, Matthew G Fury, Erminia Massarelli, Samir N Khleif

Eur J Cancer· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis